IDNNA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
IDNNA
IDNNA.png
Names
IUPAC name
[2-(4-Iodo-2,5-dimethoxyphenyl)-1-methylethyl]dimethylamine
Other names
2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine
2,5-Dimethoxy-4-iodo-1-ethyl-(alpha-methyl)amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C13H20NO2I
Molar mass 349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYNo ?)
Infobox references

IDNNA, or 2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 2.6 mg, and the duration unknown. IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also[edit]

References[edit]

  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014. 

External links[edit]